Abstract
Background/Aims: Selecting the initial antiviral regimen for chronic hepatitis B (CHB) requires balancing patients’ comorbidities and long-term safety. This study examines the differences in patient and disease-related factors that guide clinicians to prescribe either entecavir (ETV) or tenofovir disoproxil fumarate (TDF) as the initial treatment.
Materials and Methods: The study included treatment-naïve CHB patients aged 18 or older who had been diagnosed for at least 1 year since 2010 and initiated on antiviral therapy. The data included variables such as age, gender, body mass index (BMI), comorbidities, liver disease activity, biopsy results, cirrhosis, hepatic steatosis, hepatitis B e antigen status, hepatitis B virus DNA levels, triglycerides, cholesterol, renal function, and baseline bone mineral density (BMD), which were assessed by dual-energy x-ray absorptiometry (DEXA).
Results: Among 2259 patients (61.6% male), 1270 patients (56.22%) received TDF, while 989 patients (43.78%) received ETV as first line therapy. The TDF was more commonly prescribed to patients with a lower BMI (median 25.7 vs. 26.2, P = .001) and lower baseline creatinine (0.75 vs. 0.80 for ETV, P < .001). Clinicians preferred ETV among patients with an estimated glomerular filtration rate (eGFR) < 60 (n = 36), (P < .001). The BMD was evaluated in 365 patients (16.3%). The DEXA scans were performed for 116 patients (11.8%) in the ETV group and 249 patients (19.8%) in the TDF group (P < .001).
Conclusions: This national multicenter study emphasizes that patient-related factors, including gender, age, baseline renal function, and liver disease severity, significantly influence the choice of first-line antiviral therapy for CHB, often outweighing disease-specific factors.
Cite this article as: Yamazhan T, Zerdali E, Önlen Y, et al. A national multicenter study on initial antiviral treatment preferences on chronic hepatitis B: Entecavir versus tenofovir disoproxil fumarate. Turk J Gastroenterol. 2026;37(2):179-185.
Most read articles by the same author(s)
- Yusuf Önlen, Tayibe Bal, Mehmet Çabalak, Nefise Çuvalcı Öztoprak, Nagehan Didem Sarı, Behice Kurtaran, Ebubekir Şenateş, Alper Gündüz, Esra Zerdali, Hasan Karsen, Ayşe Batırel, Rıdvan Karaali, Rahmet Güner, Tansu Yamazhan, Şükran Köse, Nurettin Erben, Nevin İnce, İftihar Köksal, Figen Sarıgül Yıldırım, Gülşen Yörük, Süheyla Kömür, Sibel Kaya, Şaban Esen, Özgür Günal, İlknur Esen Yıldız, Dilara İnan, Şener Barut, Mustafa Namıduru, Selma Tosun, Kamuran Türker, Alper Şener, Kenan Hızel, Nurcan Baykam, Fazilet Duygu, Esragül Akıncı, Güray Can, Ülkü User, Hanefi Cem Gül, Ayhan Akbulut, Güven Çelebi, Mahmut Sünnetçioğlu, Oğuz Karabay, Hayat Kumbasar Karaosmanoğlu, Fatma Sırmatel, Fehmi Tabak, Efficacy and Safety of Direct-Acting Antivirals in Elderly Patients with Chronic Hepatitis C: A Nationwide Real-Life, Observational, Multicenter Study from Turkey , Turkish Journal of Gastroenterology: Vol. 33 No. 10 (2022): Turkish Journal of Gastroenterology
- Fehmi Tabak, Cihan Yurdaydın, Sabahattin Kaymakoğlu, Mesut Akarsu, Esra G. Akıncı, Hikmet Akkız, Canan Alkım, Ayhan H. Çekin, Nefise Ö. Çuvalcı, Kadir Demir, Bülent Değertekin, İlyas Dökmetaş, Galip Ersöz, Kenan Hizel, Fatma Ö. Kandemir, Yusuf Önlen, Abdullah Sonsuz, Ebubekir Şenateş, Selma Tosun, Nurdan Tözün, Ramazan Idilman, and Viral Hepatisis Guideline Study Group, Diagnosis, management and treatment of hepatitis B virus infection: Turkey 2017 Clinical Practice Guidelines , Turkish Journal of Gastroenterology: Vol. 28 No. 2 (2017): Turkish Journal of Gastroenterology
- Alper Gunduz, Nefise Çuvalcı Öztoprak, Nagehan Didem Sarı, Behice Kurtaran, Yusuf Önlen, Ebubekir Senates, Esra Zerdali, Hasan Karsen, Ayse Batırel, Rıdvan Kara Ali, Rahmet Güner, Tansu Yamazhan, Sukran Kose, Nurettin Erben, Nevin Ince, İftihar Köksal, Figen Sarıgül Yıldırım, Gulsen Yoruk, Suheyla Komur, Tayibe Bal, Sibel Kaya, Şaban Esen, Özgür Günal, Ilknur Esen Yıldız, Dilara Inan, Şener Barut, Mustafa Namıduru, Selma Tosun, Kamuran Türker, Alper Sener, Kenan Hızel, Nurcan Baykam, Fazilet Duygu, Esragül Akıncı, Güray Can, Ulku User, Hanefi Cem Gül, Ayhan Akbulut, Güven Çelebi, Mahmut Sünnetçioğlu, Oğuz Karabay, Hayat Kumbasar Karaosmanoğlu, Fatma Sırmatel, Fehmi Tabak, Efficacy and Safety of Direct-Acting Antivirals in Patients with Hepatitis C Infection: Nationwide Real-life Data from Türkiye , Turkish Journal of Gastroenterology: Vol. 37 No. 6 (2026): Turkish Journal of Gastroenterology
- Sabahattin Kaymakoğlu, İftihar Köksal, Fehmi Tabak, Ulus S. Akarca, Ayhan Akbulut, Filiz Akyüz, Hürrem Bodur, Atahan Çağatay, Dinç Dinçer, Şaban Esen, Rahmet Güner, Selim Gürel, Şükran Köse, Ömer Şentürk, Halis Şimşek, Tansu Yamazhan, Yusuf Yılmaz, Ramazan Idilman, and Viral Hepatisis Guideline Study Group, Recommendation for treatment of hepatitis C virus infection , Turkish Journal of Gastroenterology: Vol. 28 No. 2 (2017): Turkish Journal of Gastroenterology
- Cihan Yurdaydın, Fehmi Tabak, Sabahattin Kaymakoğlu, Mesut Akarsu, Esra G. Akıncı, Hikmet Akkız, Canan Alkım, Ayhan H. Çekin, Nefise Ö. Çuvalcı, Kadir Demir, Bülent Değertekin, İlyas Dökmetaş, Galip Ersöz, Kenan Hizel, Fatma Ö. Kandemir, Yusuf Önlen, Abdullah Sonsuz, Ebubekir Şenateş, Selma Tosun, Nurdan Tözün, Ramazan Idilman, and Viral Hepatisis Guideline Study Group, Diagnosis, management and treatment of hepatitis delta virus infection: Turkey 2017 Clinical Practice Guidelines , Turkish Journal of Gastroenterology: Vol. 28 No. 2 (2017): Turkish Journal of Gastroenterology
- Ramazan Idilman, Nurcan Baykam, Sabahattin Kaymakoğlu, Fehmi Tabak, Halil İ. Bahçecioğlu, Ahmet Bektaş, Cemal Bulut, Fulya Günşar, Dilara İnan, Hayat K. Karaosmanoğlu, Zeki Karasu, Ferit Kuşçu, Birgül Mete, Ömer Özbakır, Osman C. Özdoğan, Mehmet Parlak, Fatma Sırmatel, Ömer Topalak, Belkis Ünsal, and Viral Hepatisis Guideline Study Group, Turkey 2017 Clinical Practice Guidelines on recommendations for screning diagnosing and managing hepatitis C virus , Turkish Journal of Gastroenterology: Vol. 28 No. 2 (2017): Turkish Journal of Gastroenterology
- Murat Zeytunlu, Alper Uğuz, Ömer Ünalp, Orkan Ergün, Zeki Karasu, Fulya Günşar, Ulus Akarca, Funda Yılmaz, İlker Turan, Deniz Nart, Fatih Tekin, Ömer Özütemiz, Sezgin Ulukaya, Nuri Deniz, Sema Aydoğdu, Funda Özgenç, Ezgi Tasçı, Rüçhan Sertöz, Mustafa Parıldar, Nevra Elmas, Mustafa Harman, Ezgi Güler, Erkan Kısmalı, Rahmi Akyol, Tansu Yamazhan, Meltem Taşbakan, Yiğit Tiftikcioğlu, Feza Bacakoğlu, Sanem Nalbantgil, Ayşin Noyan, Bülent Karapınar, Arda Kılınç, Mehmet Uyar, Kubilay Demirağ, Sibel Özalp, Nebile Özdemir, Sinem Aras, Nurşen Altuğ, Results of 1001 liver transplantations in 23 years: Ege University experience , Turkish Journal of Gastroenterology: Vol. 29 No. 6 (2018): Turkish Journal of Gastroenterology
- Sibel Yıldız Kaya, Behice Kurtaran, Nefise Öztoprak Çuvalcı, Yusuf Önlen, Mehmet Reşat Ceylan, Esra Zerdali, Nagehan Didem Sarı, Ahsen Öncül, Nurettin Erben, Ayse Batirel, Dilara İnan, Süheyla Kömür, Figen Sarıgül Yıldırım, Hasibullah Yaqoobi, Ferit Kuscu, Rahmet Guner, Fehmi Tabak, Hep-C Türkiye Study Group, Real-Life Experience of Hepatitis C Treatment with Direct-Acting Antivirals in Genotypes 2 and 3 , Turkish Journal of Gastroenterology: Vol. 37 No. 1 (2026): Turkish Journal of Gastroenterology
- Bilgehan Aygen, Ahmet Muzaffer Demir, Mahmut Gümüş, Oğuz Karabay, Sabahattin Kaymakoğlu, Aydın Şeref Köksal, İftihar Köksal, Necati Örmeci, Fehmi Tabak, Immunosuppressive therapy and the risk of hepatitis B reactivation: Consensus report , Turkish Journal of Gastroenterology: Vol. 29 No. 3 (2018): Turkish Journal of Gastroenterology
- Necati Örmeci, Murat Taner Gülşen, Orhan Sezgin, Sevda Aghayeva, Mehmet Demir, Iftihar Köksal, Rahmet Güner, Elife Erarslan, Özgün Ömer Asiller, Ayhan Balkan, Serkan Yaraş, Aysun Çalışkan Kartal, Treatment of HCV infection with direct-acting antiviral agents. Real life experiences from the Euro-Asian region , Turkish Journal of Gastroenterology: Vol. 31 No. 2 (2020): Turkish Journal of Gastroenterology

This work is licensed under a Creative Commons Attribution 4.0 International License.